Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA)

Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA)

Introduction: Dipeptidyl peptidase 4 (DPP4) inhibitors are widely used in type 2 diabetes mellitus (T2DM) patients but the data available in existing clinical trial programmes on DPP4 inhibitors include limited number of patients from India. Hence, this study attempted to understand usage, efficacy...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, Sarita Bajaj, A G Unnikrishnan, Manash P Baruah, Rakesh Sahay, V Hardik, Amit Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
DPP4 inhibitors
Saxagliptin
type 2 diabetes mellitus
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=3;spage=312;epage=317;aulast=Kalra

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=3;spage=312;epage=317;aulast=Kalra

Similar Items